US Stock MarketDetailed Quotes

NeuroSense Therapeutics (NRSN)

Watchlist
  • 0.7070
  • -0.0010-0.14%
Close Apr 17 16:00 ET
  • 0.7600
  • +0.0530+7.50%
Post 20:01 ET
24.99MMarket Cap-1.61P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NeuroSense Therapeutics (NRSN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
11.95%11.09M
-17.82%9.9M
-42.16%1.77M
-19.76%2.11M
-10.09%3.03M
0.10%2.99M
14.17%12.05M
703.67%3.06M
-20.88%2.63M
-6.13%3.37M
Selling and administrative expenses
15.56%4.86M
-11.96%4.2M
-40.74%685K
14.98%1.23M
-16.50%1.18M
-2.37%1.11M
-3.87%4.78M
446.11%1.16M
-33.79%1.07M
-17.91%1.41M
-General and administrative expense
15.56%4.86M
-11.96%4.2M
-40.74%685K
14.98%1.23M
-16.50%1.18M
-2.37%1.11M
-3.87%4.78M
446.11%1.16M
-33.79%1.07M
-17.91%1.41M
Research and development costs
9.28%6.23M
-21.67%5.7M
-43.02%1.09M
-43.58%879K
-5.46%1.85M
1.62%1.88M
30.20%7.27M
166.57%1.91M
-8.68%1.56M
4.71%1.96M
Operating profit
-11.95%-11.09M
17.82%-9.9M
42.16%-1.77M
19.76%-2.11M
10.09%-3.03M
-0.10%-2.99M
-14.17%-12.05M
-703.67%-3.06M
20.88%-2.63M
6.13%-3.37M
Net non-operating interest income expense
102.27%7K
-14.44%-309K
98.67%-31K
-101.80%-41K
887.32%2.17M
-3,697.01%-2.41M
-421.43%-270K
-159.96%-2.34M
135.12%2.28M
48.31%-276K
Non-operating interest income
550.00%13K
-98.88%2K
----
----
----
----
95.60%178K
----
----
----
Non-operating interest expense
----
----
----
----
---2.17M
--2.41M
----
----
----
----
Total other finance cost
-98.07%6K
-30.58%311K
-98.69%33K
----
----
----
6,300.00%448K
--2.52M
----
----
Other net income (expense)
-4,800.00%-47K
-99.95%1K
10,154.55%2.21M
Gain on sale of security
-4,800.00%-47K
-99.95%1K
----
----
----
----
10,154.55%2.21M
----
----
----
Income before tax
-8.96%-11.13M
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
Income tax
Net income
-8.96%-11.13M
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
Net income continuous Operations
-8.96%-11.13M
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
Minority interest income
Net income attributable to the parent company
-8.96%-11.13M
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.96%-11.13M
-1.02%-10.21M
43.49%-1.8M
-513.71%-2.15M
76.49%-857K
-84.82%-5.4M
3.67%-10.11M
-144.78%-3.19M
88.31%-350K
-4.74%-3.65M
Basic earnings per share
18.52%-0.44
27.03%-0.54
68.42%-0.06
-0.11
93.33%-0.02
-40.00%-0.35
18.68%-0.74
-72.73%-0.19
0
3.23%-0.3
Diluted earnings per share
18.52%-0.44
27.03%-0.54
68.42%-0.06
-0.11
93.33%-0.02
-40.00%-0.35
18.68%-0.74
-72.73%-0.19
0
3.23%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(FY)Dec 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 11.95%11.09M-17.82%9.9M-42.16%1.77M-19.76%2.11M-10.09%3.03M0.10%2.99M14.17%12.05M703.67%3.06M-20.88%2.63M-6.13%3.37M
Selling and administrative expenses 15.56%4.86M-11.96%4.2M-40.74%685K14.98%1.23M-16.50%1.18M-2.37%1.11M-3.87%4.78M446.11%1.16M-33.79%1.07M-17.91%1.41M
-General and administrative expense 15.56%4.86M-11.96%4.2M-40.74%685K14.98%1.23M-16.50%1.18M-2.37%1.11M-3.87%4.78M446.11%1.16M-33.79%1.07M-17.91%1.41M
Research and development costs 9.28%6.23M-21.67%5.7M-43.02%1.09M-43.58%879K-5.46%1.85M1.62%1.88M30.20%7.27M166.57%1.91M-8.68%1.56M4.71%1.96M
Operating profit -11.95%-11.09M17.82%-9.9M42.16%-1.77M19.76%-2.11M10.09%-3.03M-0.10%-2.99M-14.17%-12.05M-703.67%-3.06M20.88%-2.63M6.13%-3.37M
Net non-operating interest income expense 102.27%7K-14.44%-309K98.67%-31K-101.80%-41K887.32%2.17M-3,697.01%-2.41M-421.43%-270K-159.96%-2.34M135.12%2.28M48.31%-276K
Non-operating interest income 550.00%13K-98.88%2K----------------95.60%178K------------
Non-operating interest expense -------------------2.17M--2.41M----------------
Total other finance cost -98.07%6K-30.58%311K-98.69%33K------------6,300.00%448K--2.52M--------
Other net income (expense) -4,800.00%-47K-99.95%1K10,154.55%2.21M
Gain on sale of security -4,800.00%-47K-99.95%1K----------------10,154.55%2.21M------------
Income before tax -8.96%-11.13M-1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M
Income tax
Net income -8.96%-11.13M-1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M
Net income continuous Operations -8.96%-11.13M-1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M
Minority interest income
Net income attributable to the parent company -8.96%-11.13M-1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.96%-11.13M-1.02%-10.21M43.49%-1.8M-513.71%-2.15M76.49%-857K-84.82%-5.4M3.67%-10.11M-144.78%-3.19M88.31%-350K-4.74%-3.65M
Basic earnings per share 18.52%-0.4427.03%-0.5468.42%-0.06-0.1193.33%-0.02-40.00%-0.3518.68%-0.74-72.73%-0.1903.23%-0.3
Diluted earnings per share 18.52%-0.4427.03%-0.5468.42%-0.06-0.1193.33%-0.02-40.00%-0.3518.68%-0.74-72.73%-0.1903.23%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -